INSIGHTS ON CLINICAL TRIAL DESIGN
-
![It works great until protocol changes]( "It Works Great Until Your Protocol Changes")
It Works Great Until Your Protocol ChangesThe CEO of Korio discusses the challenges of change and how Korio's platform addresses every shifting protocols.
-
![Checking prescription on smartphone-GettyImages-1719535353]( "Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data")
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study DataNew, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
-
![Clinical Leader Solutions Expo]( "Early Oncology Clinical Trials: Key Considerations To Plan For Success")
Early Oncology Clinical Trials: Key Considerations To Plan For SuccessThis presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
-
![Investigational insights]( "Investigational Insights: Elevating IDS Practice Through Continuing Education")
Investigational Insights: Elevating IDS Practice Through Continuing EducationDiscover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.
-
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers6/25/2026
Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.
-
Reassure Patients About Benefits Of Clinical Trial Participation10/29/2025
Gaining a patient’s trust is the first step to trial participation. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.
-
Debunking 5 Misconceptions About Community-Based Research Sites5/28/2025
By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.
-
Has Your Clinical Trial Outgrown Its RTSM Software? Here's What to Watch For3/25/2026
This clip explores how rigid RTSM systems push teams into risky manual workarounds and highlights why flexible, adaptable technology is essential when studies evolve and operational demands shift.
-
Applying AI to Study Simulation: From Design to Analysis5/12/2026
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1903972230 Sustainability Concept, Green Forest With Globe Earth]( "ecoScout For Meetings")
Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.
-
![Getty Images- 1404912459 oncology]( "Making The Impossible Possible In Oncology And Hematology Clinical Development")
When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
-
![GettyImages-1254825733 data]( "Simulants: Unlock Insights And Accelerate Medical Breakthroughs")
Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
-
![Website]( "Orchestrated Study Start-Up")
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
-
![GettyImages-1016958284 biosimilar lab]( "Every Decision Starts With The Right Biospecimen")
Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.
